Clinical trial · Interventional
Brachial Plexus Tumors; Pathological Types and Surgical Approaches: Multi Center Experience
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Brachial plexus tumors, are rare, present significant challenges due to their intricate anatomical location and potential impact on upper limb function. These tumors arise from nerve sheath cells, including either benign schwannomas and neurofibromas, or as malignant peripheral nerve sheath tumors (MPNSTs), which require early diagnosis and intervention to improve patient outcomes (1). Surgical resection remains the primary treatment modality, aiming to alleviate symptoms and prevent further neurological compromise.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brachial Plexus Tumors | Brachial Plexus Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| brachial plexus tumors excision | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- brachial plexus tumors patients
- description
- patients who has brachial plexus tumors
- interventionNames
- Procedure: brachial plexus tumors excision
Primary outcomes (2)
- measure
- 1-motor power and sensory improvment
- timeFrame
- 2 years
- description
- Clinical: Better outcome according to MRC Muscle Power Scale and Numeric Sensory Scale (NSS) The Medical Research Council (MRC) Muscle Power Scale is commonly used to assess motor power in patients. It ranges from 0 to 5, evaluating voluntary muscle contraction against gravity and resistance. The Numeric Sensory Scale (NSS) is a simple and effective tool used to assess sensory function. It is based on a numerical rating system from 0 to 10, where patients self-report their level of sensation. This scale is commonly used in neurological examinations to evaluate sensory deficits.
- measure
- Radiological out come
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: .Patients diagnosed with brachial plexus tumors confirmed through imaging .Age of Patients: Any age . .patients who are fit for surgery . Exclusion Criteria: . Patients with non-tumorous brachial plexus pathologies (e.g., trauma, inflammation). .Patients with incomplete medical records or lost follow-up data. .Patients with recurrent tumors previously treated. .Patients who are unfit for surgery.
References
Publications (0)
Data not yet available